Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
24.08
+0.23 (0.96%)
Mar 18, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts that cover Pelthos Therapeutics stock have a consensus rating of "Strong Buy" and an average price target of $54.6, which forecasts a 126.74% increase in the stock price over the next year. The lowest target is $48 and the highest is $60.
Price Target: $54.6 (+126.74%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Pelthos Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 4 | 4 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $48 | Buy | Initiates | $48 | +99.34% | Feb 27, 2026 |
| Roth Capital | Roth Capital | Strong Buy Maintains $57 → $55 | Strong Buy | Maintains | $57 → $55 | +128.41% | Feb 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $57 → $60 | Buy | Maintains | $57 → $60 | +149.17% | Jan 26, 2026 |
| Lake Street | Lake Street | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +107.64% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +149.17% | Dec 3, 2025 |
Financial Forecast
Revenue This Year
17.53M
Revenue Next Year
64.01M
from 17.53M
Increased by 265.15%
EPS This Year
-18.17
from -14.27
EPS Next Year
-9.56
from -18.17
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | 19.1M | 67.7M | ||||
| Avg | 17.5M | 64.0M | ||||
| Low | 15.9M | 59.7M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | 286.3% | ||||
| Avg | - | 265.2% | ||||
| Low | - | 240.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | -10.95 | -1.10 | ||||
| Avg | -18.17 | -9.56 | ||||
| Low | -23.92 | -15.72 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|
| High | - | - | ||||
| Avg | - | - | ||||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.